Detalhe da pesquisa
1.
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
Blood
; 138(1): 11-22, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827116
2.
Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider's Perspective.
Curr Oncol Rep
; 24(12): 1863-1872, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336769
3.
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
N Engl J Med
; 377(26): 2531-2544, 2017 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29226797
4.
A Challenging Pie to Splice: Drugging the Spliceosome.
Angew Chem Int Ed Engl
; 56(40): 12052-12063, 2017 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28371109
5.
A Carbohydrate-Derived Splice Modulator.
J Am Chem Soc
; 138(15): 5063-8, 2016 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27058259
6.
Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 22(12): 2117-2125, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27660167
7.
Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels.
Haematologica
; 105(1): e22-e25, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048356
8.
Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.
Haematologica
; 100(7): 945-54, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25862704
9.
Acute Lymphoblastic Leukemia, Version 2.2015.
J Natl Compr Canc Netw
; 13(10): 1240-79, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483064
10.
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.
Proc Natl Acad Sci U S A
; 108(32): 13253-7, 2011 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-21788521
11.
Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia.
Mol Ther Nucleic Acids
; 35(2): 102202, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38846999
12.
ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotype.
Front Oncol
; 13: 1200914, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37719008
13.
Predictors and Management of Relapse to Axicabtagene Ciloleucel in Patients with Aggressive B-cell Lymphoma.
Hematol Oncol Stem Cell Ther
; 16(2): 133-143, 2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562407
14.
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 23(6): 456-462, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003846
15.
It Is in the Eye of the Beholder: Ocular Ultrasound Enhanced Monitoring of Neurotoxicity after CAR-T Cell Therapy.
Hematol Rep
; 15(1): 1-8, 2022 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648879
16.
Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B.
Aging (Albany NY)
; 14(5): 2081-2100, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230971
17.
Extracorporeal photopheresis for the treatment of chronic graft versus host disease.
Hematology
; 27(1): 785-794, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802815
18.
Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576.
Adv Hematol
; 2022: 4450824, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35103064
19.
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience.
Leuk Lymphoma
; 63(6): 1363-1368, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35109766
20.
Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a.
Proc Natl Acad Sci U S A
; 105(8): 3047-52, 2008 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-18287027